Dr. Silva is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 St Paul Dr
Chambersburg, PA 17201Phone+1 724-543-8657Fax+1 724-543-8656
Education & Training
- UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2000 - 2003
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1997 - 2000
- Universidade de São PauloInternship, 1996 - 1997
- Federal University of Bahia Faculty of MedicineClass of 1995
Certifications & Licensure
- PA State Medical License 1998 - 2024
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Clinical research training program graduate University of pittsburgh School of Medicine, 2001-2003
Publications & Presentations
PubMed
- 40 citationsAn IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy.Peter H. Liu, Richa B. Shah, Yuanyuan Li, Arshi Arora, Peter Man-Un Ung
Nature Cell Biology. 2019-01-21 - 23 citationsNetwork-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer.Tizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, Maika Onishi, Yuxin Li
Nature Cancer. 2023-02-01 - 2 citationsReply to: Ricolinostat is not a highly selective HDAC6 inhibitor.Jose Silva, Jiyang Yu, Kevin Kalinsky
Nature Cancer. 2023-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: